Pharma & Healthcare
Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Insights, Forecast to 2030
- Mar 07, 25
- ID: 1312
- Pages: 111
- Figures: 134
- Views: 30
Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is maternal inheritance, or mitochondrial inheritance, caused by mutations in mitochondrial DNA11778, 14484 or 3460.It's a common type of inherited optic neuropathy. Related drugs include oxygen, ribonucleic acid, arginine, aidibenzoquinone, vitamin C, unoprostol.
The global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) include Alkeus Pharmaceuticals, Amgen, Biovista, Editas Medicine, GenSight Biologics, Ixchel Pharma, Khondrion, Mitotech and ProQR Therapeutics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Biovista
Editas Medicine
GenSight Biologics
Ixchel Pharma
Khondrion
Mitotech
ProQR Therapeutics
Sanofi
Spark Therapeutics
Stealth BioTherapeutics
Usher Syndrome
Segment by Type
Dominant Optic Atrophy
Recessive Optic Atrophy
Segment by Application
Hospitals
Eye Clinics
Medical Research Institute
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) include Alkeus Pharmaceuticals, Amgen, Biovista, Editas Medicine, GenSight Biologics, Ixchel Pharma, Khondrion, Mitotech and ProQR Therapeutics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), also provides the sales of main regions and countries. Highlights of the upcoming market potential for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Biovista
Editas Medicine
GenSight Biologics
Ixchel Pharma
Khondrion
Mitotech
ProQR Therapeutics
Sanofi
Spark Therapeutics
Stealth BioTherapeutics
Usher Syndrome
Segment by Type
Dominant Optic Atrophy
Recessive Optic Atrophy
Segment by Application
Hospitals
Eye Clinics
Medical Research Institute
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Introduction
1.2 Market by Type
1.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Dominant Optic Atrophy
1.2.3 Recessive Optic Atrophy
1.3 Market by Application
1.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Medical Research Institute
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Estimates and Forecasts 2019-2030
2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region
2.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2019-2024)
2.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2025-2030)
2.2.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2019-2030)
2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Estimates and Forecasts 2019-2030
2.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region
2.4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2019-2024)
2.4.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2025-2030)
2.4.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Manufacturers
3.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Manufacturers (2019-2024)
3.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in 2023
3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Manufacturers
3.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Manufacturers (2019-2024)
3.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue in 2023
3.3 Global Key Players of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Product Offered and Application
3.8 Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type
4.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historical Sales by Type (2019-2024)
4.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Sales by Type (2025-2030)
4.1.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)
4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type
4.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historical Revenue by Type (2019-2024)
4.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Revenue by Type (2025-2030)
4.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)
4.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type
4.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2019-2024)
4.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application
5.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historical Sales by Application (2019-2024)
5.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Sales by Application (2025-2030)
5.1.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)
5.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application
5.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historical Revenue by Application (2019-2024)
5.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Revenue by Application (2025-2030)
5.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)
5.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application
5.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2019-2024)
5.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type
6.1.1 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2030)
6.1.2 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2030)
6.2 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application
6.2.1 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)
6.2.2 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)
6.3 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country
6.3.1 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2030)
6.3.3 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type
7.1.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2030)
7.1.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2030)
7.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application
7.2.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)
7.2.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)
7.3 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country
7.3.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2030)
7.3.3 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size
8.1.1 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (2019-2030)
8.1.2 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030)
8.2 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application
8.2.1 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)
8.2.2 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type
9.1.1 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2030)
9.1.2 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2030)
9.2 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application
9.2.1 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)
9.2.2 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)
9.3 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region
9.3.1 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2019-2030)
9.3.3 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type
10.1.1 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application
10.2.1 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
10.3.1 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Alkeus Pharmaceuticals
11.1.1 Alkeus Pharmaceuticals Company Information
11.1.2 Alkeus Pharmaceuticals Overview
11.1.3 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Alkeus Pharmaceuticals Recent Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Overview
11.2.3 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 Biovista
11.3.1 Biovista Company Information
11.3.2 Biovista Overview
11.3.3 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biovista Recent Developments
11.4 Editas Medicine
11.4.1 Editas Medicine Company Information
11.4.2 Editas Medicine Overview
11.4.3 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Editas Medicine Recent Developments
11.5 GenSight Biologics
11.5.1 GenSight Biologics Company Information
11.5.2 GenSight Biologics Overview
11.5.3 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GenSight Biologics Recent Developments
11.6 Ixchel Pharma
11.6.1 Ixchel Pharma Company Information
11.6.2 Ixchel Pharma Overview
11.6.3 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ixchel Pharma Recent Developments
11.7 Khondrion
11.7.1 Khondrion Company Information
11.7.2 Khondrion Overview
11.7.3 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Khondrion Recent Developments
11.8 Mitotech
11.8.1 Mitotech Company Information
11.8.2 Mitotech Overview
11.8.3 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mitotech Recent Developments
11.9 ProQR Therapeutics
11.9.1 ProQR Therapeutics Company Information
11.9.2 ProQR Therapeutics Overview
11.9.3 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ProQR Therapeutics Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Information
11.10.2 Sanofi Overview
11.10.3 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sanofi Recent Developments
11.11 Spark Therapeutics
11.11.1 Spark Therapeutics Company Information
11.11.2 Spark Therapeutics Overview
11.11.3 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Spark Therapeutics Recent Developments
11.12 Stealth BioTherapeutics
11.12.1 Stealth BioTherapeutics Company Information
11.12.2 Stealth BioTherapeutics Overview
11.12.3 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Stealth BioTherapeutics Recent Developments
11.13 Usher Syndrome
11.13.1 Usher Syndrome Company Information
11.13.2 Usher Syndrome Overview
11.13.3 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Usher Syndrome Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Chain Analysis
12.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Mode & Process
12.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Marketing
12.4.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Channels
12.4.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors
12.5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers
13 Market Dynamics
13.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Trends
13.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers
13.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges
13.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints
14 Key Findings in The Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Introduction
1.2 Market by Type
1.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Dominant Optic Atrophy
1.2.3 Recessive Optic Atrophy
1.3 Market by Application
1.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Medical Research Institute
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Estimates and Forecasts 2019-2030
2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region
2.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2019-2024)
2.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2025-2030)
2.2.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2019-2030)
2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Estimates and Forecasts 2019-2030
2.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region
2.4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2019-2024)
2.4.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2025-2030)
2.4.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Manufacturers
3.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Manufacturers (2019-2024)
3.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in 2023
3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Manufacturers
3.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Manufacturers (2019-2024)
3.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue in 2023
3.3 Global Key Players of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Product Offered and Application
3.8 Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type
4.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historical Sales by Type (2019-2024)
4.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Sales by Type (2025-2030)
4.1.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)
4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type
4.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historical Revenue by Type (2019-2024)
4.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Revenue by Type (2025-2030)
4.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)
4.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type
4.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2019-2024)
4.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application
5.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historical Sales by Application (2019-2024)
5.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Sales by Application (2025-2030)
5.1.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)
5.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application
5.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Historical Revenue by Application (2019-2024)
5.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Forecasted Revenue by Application (2025-2030)
5.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)
5.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application
5.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2019-2024)
5.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type
6.1.1 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2030)
6.1.2 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2030)
6.2 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application
6.2.1 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)
6.2.2 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)
6.3 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country
6.3.1 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2030)
6.3.3 US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type
7.1.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2030)
7.1.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2030)
7.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application
7.2.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)
7.2.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)
7.3 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country
7.3.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2030)
7.3.3 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size
8.1.1 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (2019-2030)
8.1.2 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030)
8.2 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application
8.2.1 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)
8.2.2 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type
9.1.1 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2030)
9.1.2 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2030)
9.2 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application
9.2.1 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)
9.2.2 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)
9.3 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region
9.3.1 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2019-2030)
9.3.3 Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type
10.1.1 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application
10.2.1 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country
10.3.1 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Alkeus Pharmaceuticals
11.1.1 Alkeus Pharmaceuticals Company Information
11.1.2 Alkeus Pharmaceuticals Overview
11.1.3 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Alkeus Pharmaceuticals Recent Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Overview
11.2.3 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 Biovista
11.3.1 Biovista Company Information
11.3.2 Biovista Overview
11.3.3 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biovista Recent Developments
11.4 Editas Medicine
11.4.1 Editas Medicine Company Information
11.4.2 Editas Medicine Overview
11.4.3 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Editas Medicine Recent Developments
11.5 GenSight Biologics
11.5.1 GenSight Biologics Company Information
11.5.2 GenSight Biologics Overview
11.5.3 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GenSight Biologics Recent Developments
11.6 Ixchel Pharma
11.6.1 Ixchel Pharma Company Information
11.6.2 Ixchel Pharma Overview
11.6.3 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ixchel Pharma Recent Developments
11.7 Khondrion
11.7.1 Khondrion Company Information
11.7.2 Khondrion Overview
11.7.3 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Khondrion Recent Developments
11.8 Mitotech
11.8.1 Mitotech Company Information
11.8.2 Mitotech Overview
11.8.3 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mitotech Recent Developments
11.9 ProQR Therapeutics
11.9.1 ProQR Therapeutics Company Information
11.9.2 ProQR Therapeutics Overview
11.9.3 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ProQR Therapeutics Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Information
11.10.2 Sanofi Overview
11.10.3 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sanofi Recent Developments
11.11 Spark Therapeutics
11.11.1 Spark Therapeutics Company Information
11.11.2 Spark Therapeutics Overview
11.11.3 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Spark Therapeutics Recent Developments
11.12 Stealth BioTherapeutics
11.12.1 Stealth BioTherapeutics Company Information
11.12.2 Stealth BioTherapeutics Overview
11.12.3 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Stealth BioTherapeutics Recent Developments
11.13 Usher Syndrome
11.13.1 Usher Syndrome Company Information
11.13.2 Usher Syndrome Overview
11.13.3 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Usher Syndrome Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Chain Analysis
12.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Mode & Process
12.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Marketing
12.4.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Channels
12.4.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors
12.5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers
13 Market Dynamics
13.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Trends
13.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers
13.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges
13.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints
14 Key Findings in The Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Dominant Optic Atrophy
Table 3. Major Manufacturers of Recessive Optic Atrophy
Table 4. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2019-2024)
Table 9. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2025-2030)
Table 10. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2019-2024) & (K Pcs)
Table 12. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2025-2030) & (K Pcs)
Table 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2019-2024)
Table 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2025-2030)
Table 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Manufacturers (2019-2024) & (K Pcs)
Table 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Manufacturers (2019-2024)
Table 17. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Manufacturers 2019-2024 (USD/Piece)
Table 21. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) as of 2023)
Table 23. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Product Offered and Application
Table 25. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)
Table 28. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)
Table 29. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Type (2019-2024)
Table 30. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Type (2025-2030)
Table 31. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Type (2019-2024)
Table 34. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Type (2025-2030)
Table 35. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2019-2024) & (USD/Piece)
Table 36. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price Forecast by Type (2025-2030) & (USD/Piece)
Table 37. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)
Table 38. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)
Table 39. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Application (2019-2024)
Table 40. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Application (2025-2030)
Table 41. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Application (2019-2024)
Table 44. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Application (2025-2030)
Table 45. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2019-2024) & (USD/Piece)
Table 46. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price Forecast by Application (2025-2030) & (USD/Piece)
Table 47. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)
Table 48. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)
Table 49. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)
Table 52. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)
Table 53. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2024) & (K Pcs)
Table 59. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2025-2030) & (K Pcs)
Table 60. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)
Table 61. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)
Table 62. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)
Table 65. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)
Table 66. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2024) & (K Pcs)
Table 72. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2025-2030) & (K Pcs)
Table 73. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)
Table 74. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)
Table 75. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)
Table 78. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)
Table 79. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)
Table 82. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)
Table 83. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)
Table 86. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)
Table 87. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2019-2024) & (K Pcs)
Table 93. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2025-2030) & (K Pcs)
Table 94. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)
Table 95. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)
Table 96. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)
Table 99. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)
Table 100. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2024) & (K Pcs)
Table 106. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2025-2030) & (K Pcs)
Table 107. Alkeus Pharmaceuticals Company Information
Table 108. Alkeus Pharmaceuticals Description and Major Businesses
Table 109. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 110. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Alkeus Pharmaceuticals Recent Developments
Table 112. Amgen Company Information
Table 113. Amgen Description and Major Businesses
Table 114. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 115. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Amgen Recent Developments
Table 117. Biovista Company Information
Table 118. Biovista Description and Major Businesses
Table 119. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 120. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Biovista Recent Developments
Table 122. Editas Medicine Company Information
Table 123. Editas Medicine Description and Major Businesses
Table 124. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 125. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Editas Medicine Recent Developments
Table 127. GenSight Biologics Company Information
Table 128. GenSight Biologics Description and Major Businesses
Table 129. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 130. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. GenSight Biologics Recent Developments
Table 132. Ixchel Pharma Company Information
Table 133. Ixchel Pharma Description and Major Businesses
Table 134. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 135. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Ixchel Pharma Recent Developments
Table 137. Khondrion Company Information
Table 138. Khondrion Description and Major Businesses
Table 139. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 140. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Khondrion Recent Developments
Table 142. Mitotech Company Information
Table 143. Mitotech Description and Major Businesses
Table 144. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 145. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Mitotech Recent Developments
Table 147. ProQR Therapeutics Company Information
Table 148. ProQR Therapeutics Description and Major Businesses
Table 149. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 150. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. ProQR Therapeutics Recent Developments
Table 152. Sanofi Company Information
Table 153. Sanofi Description and Major Businesses
Table 154. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 155. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Sanofi Recent Developments
Table 157. Spark Therapeutics Company Information
Table 158. Spark Therapeutics Description and Major Businesses
Table 159. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 160. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Spark Therapeutics Recent Developments
Table 162. Stealth BioTherapeutics Company Information
Table 163. Stealth BioTherapeutics Description and Major Businesses
Table 164. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 165. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Stealth BioTherapeutics Recent Developments
Table 167. Usher Syndrome Company Information
Table 168. Usher Syndrome Description and Major Businesses
Table 169. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 170. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Usher Syndrome Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List
Table 175. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers List
Table 176. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Trends
Table 177. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers
Table 178. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges
Table 179. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Picture
Figure 2. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Type in 2023 & 2030
Figure 4. Dominant Optic Atrophy Product Picture
Figure 5. Recessive Optic Atrophy Product Picture
Figure 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. Eye Clinics
Figure 10. Medical Research Institute
Figure 11. Other
Figure 12. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Report Years Considered
Figure 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2019-2030 (US$ Million)
Figure 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2019-2030)
Figure 17. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2019-2030 ((K Pcs)
Figure 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)
Figure 20. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)
Figure 22. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)
Figure 24. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)
Figure 26. Asia (excluding China) Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)
Figure 28. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in the World: Market Share by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue in 2023
Figure 31. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)
Figure 33. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)
Figure 34. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)
Figure 35. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Country (2019-2030)
Figure 41. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Country (2019-2030)
Figure 42. U.S. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)
Figure 45. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)
Figure 46. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)
Figure 47. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)
Figure 48. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Country (2019-2030)
Figure 49. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Country (2019-2030)
Figure 50. Germany Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 51. France Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 55. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)
Figure 56. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)
Figure 57. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)
Figure 58. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)
Figure 59. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)
Figure 60. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)
Figure 61. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)
Figure 62. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)
Figure 63. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Region (2019-2030)
Figure 64. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Region (2019-2030)
Figure 65. Japan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 69. India Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Country (2019-2030)
Figure
Table 1. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Dominant Optic Atrophy
Table 3. Major Manufacturers of Recessive Optic Atrophy
Table 4. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2019-2024)
Table 9. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2025-2030)
Table 10. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2019-2024) & (K Pcs)
Table 12. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2025-2030) & (K Pcs)
Table 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2019-2024)
Table 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2025-2030)
Table 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Manufacturers (2019-2024) & (K Pcs)
Table 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Manufacturers (2019-2024)
Table 17. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Manufacturers 2019-2024 (USD/Piece)
Table 21. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) as of 2023)
Table 23. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Product Offered and Application
Table 25. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)
Table 28. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)
Table 29. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Type (2019-2024)
Table 30. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Type (2025-2030)
Table 31. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Type (2019-2024)
Table 34. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Type (2025-2030)
Table 35. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2019-2024) & (USD/Piece)
Table 36. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price Forecast by Type (2025-2030) & (USD/Piece)
Table 37. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)
Table 38. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)
Table 39. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Application (2019-2024)
Table 40. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Application (2025-2030)
Table 41. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Application (2019-2024)
Table 44. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Application (2025-2030)
Table 45. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2019-2024) & (USD/Piece)
Table 46. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price Forecast by Application (2025-2030) & (USD/Piece)
Table 47. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)
Table 48. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)
Table 49. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)
Table 52. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)
Table 53. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2024) & (K Pcs)
Table 59. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2025-2030) & (K Pcs)
Table 60. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)
Table 61. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)
Table 62. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)
Table 65. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)
Table 66. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2024) & (K Pcs)
Table 72. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2025-2030) & (K Pcs)
Table 73. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)
Table 74. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)
Table 75. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)
Table 78. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)
Table 79. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)
Table 82. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)
Table 83. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)
Table 86. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)
Table 87. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2019-2024) & (K Pcs)
Table 93. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2025-2030) & (K Pcs)
Table 94. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024) & (K Pcs)
Table 95. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030) & (K Pcs)
Table 96. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024) & (K Pcs)
Table 99. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030) & (K Pcs)
Table 100. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2024) & (K Pcs)
Table 106. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2025-2030) & (K Pcs)
Table 107. Alkeus Pharmaceuticals Company Information
Table 108. Alkeus Pharmaceuticals Description and Major Businesses
Table 109. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 110. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Alkeus Pharmaceuticals Recent Developments
Table 112. Amgen Company Information
Table 113. Amgen Description and Major Businesses
Table 114. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 115. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Amgen Recent Developments
Table 117. Biovista Company Information
Table 118. Biovista Description and Major Businesses
Table 119. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 120. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Biovista Recent Developments
Table 122. Editas Medicine Company Information
Table 123. Editas Medicine Description and Major Businesses
Table 124. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 125. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Editas Medicine Recent Developments
Table 127. GenSight Biologics Company Information
Table 128. GenSight Biologics Description and Major Businesses
Table 129. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 130. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. GenSight Biologics Recent Developments
Table 132. Ixchel Pharma Company Information
Table 133. Ixchel Pharma Description and Major Businesses
Table 134. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 135. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Ixchel Pharma Recent Developments
Table 137. Khondrion Company Information
Table 138. Khondrion Description and Major Businesses
Table 139. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 140. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Khondrion Recent Developments
Table 142. Mitotech Company Information
Table 143. Mitotech Description and Major Businesses
Table 144. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 145. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Mitotech Recent Developments
Table 147. ProQR Therapeutics Company Information
Table 148. ProQR Therapeutics Description and Major Businesses
Table 149. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 150. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. ProQR Therapeutics Recent Developments
Table 152. Sanofi Company Information
Table 153. Sanofi Description and Major Businesses
Table 154. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 155. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Sanofi Recent Developments
Table 157. Spark Therapeutics Company Information
Table 158. Spark Therapeutics Description and Major Businesses
Table 159. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 160. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Spark Therapeutics Recent Developments
Table 162. Stealth BioTherapeutics Company Information
Table 163. Stealth BioTherapeutics Description and Major Businesses
Table 164. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 165. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Stealth BioTherapeutics Recent Developments
Table 167. Usher Syndrome Company Information
Table 168. Usher Syndrome Description and Major Businesses
Table 169. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)
Table 170. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Usher Syndrome Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List
Table 175. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers List
Table 176. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Trends
Table 177. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers
Table 178. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges
Table 179. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Picture
Figure 2. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Type in 2023 & 2030
Figure 4. Dominant Optic Atrophy Product Picture
Figure 5. Recessive Optic Atrophy Product Picture
Figure 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. Eye Clinics
Figure 10. Medical Research Institute
Figure 11. Other
Figure 12. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Report Years Considered
Figure 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2019-2030 (US$ Million)
Figure 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2019-2030)
Figure 17. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2019-2030 ((K Pcs)
Figure 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)
Figure 20. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)
Figure 22. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)
Figure 24. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)
Figure 26. Asia (excluding China) Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales YoY (2019-2030) & (K Pcs)
Figure 28. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in the World: Market Share by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue in 2023
Figure 31. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)
Figure 33. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)
Figure 34. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)
Figure 35. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Country (2019-2030)
Figure 41. US & Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Country (2019-2030)
Figure 42. U.S. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)
Figure 45. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)
Figure 46. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)
Figure 47. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)
Figure 48. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Country (2019-2030)
Figure 49. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Country (2019-2030)
Figure 50. Germany Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 51. France Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 55. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)
Figure 56. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)
Figure 57. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)
Figure 58. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)
Figure 59. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)
Figure 60. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)
Figure 61. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)
Figure 62. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)
Figure 63. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Region (2019-2030)
Figure 64. Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Region (2019-2030)
Figure 65. Japan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 69. India Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Country (2019-2030)
Figure
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Gadolinium DOTA Meglumine Market Research Report 2025
Apr 23, 25
Global Crisaborole API Market Research Report 2025
Apr 23, 25
Global Glyceryl Monooleate Market Research Report 2025
Apr 23, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232